Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;331:1337 (3 December), doi:10.1136/bmj.331.7528.1337-b
| The first 150 words of the full text of this article appear below. |
EDITORWe recently conducted a qualitative evaluation study assessing the impact of mental health nurse supplementary nurse prescribing, addressing some of the issues raised by Avery and Pringle.1
Eleven service users, most with a diagnosis of psychosis, were interviewed about their experiences of the prescribing scheme, as were 12 consultant psychiatrist independent prescribers and 11 trained nurse prescribers. At the time of the interviews, eight of the nurse prescribers had prescribed psychiatric drugs.
The interviews for the nurses and psychiatrists focused on the quality of the training, support, and supervision; physical health care; and the experiences of providing a prescribing intervention. The service user interviews focused on their perception of involvement in treatment decisions, the management of adverse effects, and the quality of the relationship with the prescribing nurse.
Some key themes emerged from the data. Service users reported that nurse prescribers provided a greater focus on collaboration and
Martin Jones, nurse consultant
martin.jones@thh.nhs.uk
Hillingdon Primary Care Trust, Middlesex UB8 3NN
Dawn Miller, research assistant, Ben Lucas, clinical director for adult mental health
Hillingdon Primary Care Trust, Middlesex UB8 3NN
Joanna Bennett, workforce development lead
Sainsbury Centre for Mental Health, London SE1 1LB
Richard Gray, senior lecturer
King's College London, Institute of Psychiatry, London SE5 8AE